RECURIUM EQUITY, LLC reported 1 transaction at ZENTALIS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/30/2020ACC: 0001725160-20-000024
10% Owner
Since Apr 2020
-4.15M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.15M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.15M
Price / share
—
Trade value
—
% of position
99.6%
10/28/2020
4.16M→14.99K
Total
Net shares
−4.15M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/28/2020 | J · J | −4.15M | — | — | 99.6% | 4.16M | 14.99K |
| Total | −4.15M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported